TRIBOVAX T

SECTION 2: Hazards identification

EMERGENCY OVERVIEW Light brown to amber Viscous liquid Odor unknown May be irritating to eyes, skin or respiratory tract. May cause allergic reactions in susceptible individuals. May cause effects to: gastrointestinal tract liver kidney

Potential health effects

The toxicological properties of the mixture(s) have not been fully characterized in humans or animals. However, there are data to describe the toxicological properties of the individual ingredients. The following summary is based upon available information about the individual ingredients of the mixture(s), or of the expected properties of the mixture(s). Only information about the ingredients that are expected to contribute significantly to the

Health hazards

profile of the formulation(s) are presented This product is a vaccine for use in animals. Pathogenic clostridial bactrial strains may cause infection to damaged skin. Local irritation to the eyes, skin, or respiratory tract may occur following direct contact or inhalation of the product. As with any vaccine, exposure may cause hypersensitvity reactions. Potassium aluminum sulfate dodecahydrate, an ingredient in this product, is an astringent (causes contraction of the tissues). Alum compounds are mucous membrane irritants. Inhalation of dust or mist causes irritation to the eyes, nose, mouth, and respiratory tract. Prolonged dermal contact may cause a numbing sensation in the fingers. Ingestion of alum compounds may cause cramping, nausea, vomiting and bleeding and inflammation of the mucous membrane of the stomach and intestine. Alum compounds have also been reported to cause liver damage following acute and chronic exposure, as well as, liver and renal necrosis in animal studies. LISTED CARCINOGENS No carcinogens or potential carcinogens listed by IARC or EU Directive 90/394 (Annex I) in this mixture.